Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wanbury Limited ( (IN:WANBURY) ) just unveiled an announcement.
Wanbury Limited’s Day-to-Day Affairs Committee of the Board of Directors approved the allotment of 250 Unlisted, Secured Redeemable, Non-Convertible Debentures to Tata Capital Limited, amounting to Rs. 25 Crores. This move aims to finance the company’s capital expenditure and working capital requirements, as well as address identified liabilities, potentially strengthening its financial position and operational capabilities.
More about Wanbury Limited
Wanbury Limited operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its diverse range of healthcare solutions and has a significant market presence in India.
Average Trading Volume: 9,238
Technical Sentiment Signal: Buy
Current Market Cap: 8.14B INR
Learn more about WANBURY stock on TipRanks’ Stock Analysis page.